News Agency
Men's Weekly

Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion

  • Written by PR Newswire
Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion

SAN DIEGO and SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Bio4t2® received regulatory approvals to repeatedly administer patients with T cells engineered to express a chimeric antigen receptor (CAR) targeting BT-001, an antigen on solid tumors identified using the PrismCore platform. The CAR-T, termed B4t2-001, are predicted to engraft...

Read more: Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without...

Improving Internal Feedback Loops Through CMS-Based Commenting and Versioning

Collaboration is essential for successful digital content creation. Unfortunately, in many companies, the feedback mechanism between marketing, design, product and development functions is less than cohesive. For example, feedback is left in email chains, instant chat messages, or within locked... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion